(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(-0.07%) $80.00
(0.46%) $2.64
(0.10%) $2 419.80
(1.65%) $31.78
(0.43%) $1 094.70
(-0.03%) $0.920
(-0.01%) $10.69
(-0.19%) $0.788
(0.02%) $90.89
Live Chart Being Loaded With Signals
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally...
Stats | |
---|---|
Dagens volum | 4 121.00 |
Gjennomsnittsvolum | 10 901.00 |
Markedsverdi | 21.43M |
EPS | $0 ( 2024-05-14 ) |
Neste inntjeningsdato | ( $0 ) 2024-08-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.43 |
ATR14 | $0.0170 (1.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Krogulski Kenneth | Buy | 5 000 | Common Stock |
2024-03-25 | Jones James | Buy | 1 000 | Common Stock |
2024-03-25 | Galante Joseph C | Buy | 1 000 | Common Stock |
2024-03-25 | Young Caroline | Buy | 1 000 | Common Stock |
2024-03-25 | Brown Martin S Jr | Buy | 1 000 | Common Stock |
INSIDER POWER |
---|
64.38 |
Last 100 transactions |
Buy: 135 322 | Sell: 29 102 |
Cumberland Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
DMRC | 0.907 |
GTEC | 0.894 |
LUNA | 0.893 |
NEPH | 0.893 |
AZ | 0.891 |
DLHC | 0.888 |
TELA | 0.888 |
ZS | 0.886 |
TACT | 0.883 |
MTEM | 0.881 |
10 Mest negative korrelasjoner | |
---|---|
IGLD | -0.878 |
ROOT | -0.873 |
STAA | -0.868 |
KNTK | -0.866 |
VTVT | -0.864 |
KALU | -0.863 |
VITL | -0.862 |
PPTA | -0.861 |
TIGO | -0.861 |
BNR | -0.86 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Cumberland Økonomi
Annual | 2023 |
Omsetning: | $39.55M |
Bruttogevinst: | $28.55M (72.18 %) |
EPS: | $-0.440 |
FY | 2023 |
Omsetning: | $39.55M |
Bruttogevinst: | $28.55M (72.18 %) |
EPS: | $-0.440 |
FY | 2022 |
Omsetning: | $42.01M |
Bruttogevinst: | $32.89M (78.29 %) |
EPS: | $-0.390 |
FY | 2021 |
Omsetning: | $35.99M |
Bruttogevinst: | $27.17M (75.51 %) |
EPS: | $-0.240 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cumberland
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.